Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Biome Australia’s (BIO) activated probiotics are set to be sold in Priceline pharmacies across Australia after signing a distribution agreement
  • The microbiome health company signed the agreement with Australian Pharmaceutical Industries (API) to sell the probiotics as core range in 370 pharmacies, starting between June and July this year
  • The move grows the companies distribution points to 3000 — a 50 per cent increase sine Biome’s IPO in November 2021
  • Biome Australia was up 10 per cent, trading at 11 cents per share at 12:07 pm AEST

Biome Australia’s (BIO) activated probiotics are set to be sold in Priceline pharmacies across Australia after signing a distribution agreement.

The microbiome health company signed the agreement with Australian Pharmaceutical Industries (API) — of which Priceline is a subsidiary — to sell the probiotics as core range in 370 pharmacies, with an initial allocation of the product range to be sold between June and July this year.

The company said the new partnership will have a positive impact on revenue growth, with access to new accounts and customers, and growing to 3000 distribution points — a 50 per cent increase since Biome’s IPO on November 30, 2021.

The move has also been backed by API’s new owners Wesfarmers Group (WES).

“Distribution of Biome’s flagship Activated Probiotics product range via Priceline Pharmacy presents an exciting opportunity for us to impact more patient lives in Australian communities,” Biome Australia Managing Director Blair Norfolk said.

“We are proud to support the evolving health service focus of Priceline Pharmacy with our Activated Probiotics practitioner-only range.”

Meanwhile, Priceline Pharmacy General Manager Andrew Vidler said Biome’s probiotic product range adds to the pharmaceutical chain’s health proposition for customers.

“We know that Australians want to make informed decisions about their health, and as a result, are increasingly seeking scientifically-backed products to support their health aspirations,” Mr Vidler said.

Biome Australia shares were up 10 per cent, trading at 11 cents at 12:07 pm AEST.

BIO by the numbers
More From The Market Herald
Cavalier Resources (ASX:CVR) - Executive Technical Director, Daniel Tuffin

" Cavalier Resources (ASX:CVR) begins PFS at Crawford

Cavalier Resources (ASX:CVR) has begun a pre-feasibility study (PFS) at the Crawford Gold Project within the…
Ten Sixty Four (ASX:X64) - Outgoing Managing Director, Paul Ryan Welker

" Ten Sixty Four (ASX:X64) terminates services agreement of former MD, Paul Ryan Welker

Ten Sixty Four (ASX:X64) has terminated the executive services agreement of former Managing Director Paul Ryan…

" M3 Mining (ASX:M3M) identifies drill targets at Edjudina

M3 Mining (ASX:M3M) has identified prospective gold-in-soil anomalies at the Edjudina gold project 150 kilometres northeast…

" Good Drinks Australia (ASX:GDA) commences the sale of Molson Coors and Magners

Good Drinks Australia (ASX:GDA) begins to sell the Miller Chill, Miller Genuine Draught, Coors, Molson Canadian…